Complicaciones tromboembólicas y hemorrágicas en pacientes portadores de prótesis valvulares del corazón en un centro de tercer nivel. ¿Qué hemos aprendido? / Thromboembolic and hemorrhagic complications in patients with prosthetic heart valves at third level care center. What have we learned?

Resumen Antecedentes: El reemplazo valvular por prótesis mecánicas o biológicas implica riesgo de tromboembolismo y complicaciones hemorrágicas. Objetivo: Determinar las complicaciones relacionadas con la terapia de anticoagulación complementaria y la probabilidad de riesgo en pacientes portadores de prótesis valvulares del corazón. Métodos: Se estudiaron 163 pacientes entre 2002 y 2016, portadores de prótesis mecánicas y biológicas, quienes recibieron antagonistas de la vitamina K posterior al egreso hospitalario. La terapia de anticoagulación se categorizó en óptima y no óptima conforme a los valores de INR previos a las complicaciones. Fueron excluidos los pacientes con comorbilidades y otros factores de riesgo de trombosis y/o sangrado. Resultados: a 68.7 % de los pacientes se les colocó prótesis mecánica y a 31.3 %, biológica (p ≤ 0.001); 25.2 % presentó las complicaciones motivo de estudio (p ≤ 0.001), hemorrágicas en 48.8 %, tromboembólicas en 26.8 % y de ambos tipos en 24.4 % (riesgo relativo = 4.229); a 95.1 % de los pacientes con complicaciones se les colocó prótesis mecánica y a 4.9 %, biológica (p = 0.005); 49.7 % presentó INR no óptimo (p ≤ 0.001). Conclusiones: Ante riesgo alto de complicaciones tromboembólicas y hemorrágicas, la elección de las prótesis valvulares, la prevención y el seguimiento son prioridades, principalmente en quienes requieren terapia de anticoagulación.

Abstract Background: Heart valve replacement surgery with mechanical or biological prostheses entails a risk of thromboembolism and bleeding complications. Objective: To determine the complications related to complementary anticoagulation therapy and the probability of risk. Methods: One-hundred and sixty-three patients who underwent heart valve replacement between 2002 and 2016 with either mechanical or biological prostheses, and who received vitamin K antagonists after hospital discharge, were studied. Anticoagulation therapy was categorized into optimal and non-optimal according to INR values prior to the development of complications. Patients with comorbidities and other risk factors for thrombosis and/or bleeding were excluded. Results: In total, 68.7 % of patients received mechanical prostheses, and 31.3 %, biological prostheses (p ≤ 0.001); 25.2 % experienced the complications that motivated the study (p ≤ 0.001), which were hemorrhagic in 48.8 %, thromboembolic in 26.8 %, and of both types in 24.4 % (relative risk = 4.229). Among the patients with complications, 95.1 % received mechanical prostheses, and 4.9 %, biological (p = 0.005); non-optimal INR was identified in 49.7 % (p ≤ 0.001). Conclusions: Given the high risk of thromboembolic and hemorrhagic complications, valve prostheses must be carefully chosen, and care priorities should include prevention and follow-up, especially in those patients who require anticoagulation therapy.

Clinicohematological study of thrombocytosis.

Objective. To find out etiology and clinical course of thrombocytosis in Indian pediatric population. Methods. A total of 250 patients having thrombocytosis (defined as platelet count >500 x 109/L) on haematological investigations were studied over one yr period. All patients were evaluated clinically and were subjected to investigations, including complete blood counts (CBC) with peripheral smear examination. To elucidate the possible role of inflammatory cytokines in pathogenesis of RT, levels of Interleukin-6 (IL-6) and C - reactive protein (CRP) were estimated. Results. Infants and young children (<2 yr age) were most common group, contributing 60% of total cases. Out of total 250 cases, only 3 (1.2%) cases were found to have primary thrombocytosis and remaining 98.8% cases were having RT. Among RT patients, infections (alone or in association with iron deficiency anemia) were most common cause, accounting for 65% cases, while iron deficiency anemia (IDA) was second most common cause accounting for 41.3% cases (12.6% IDA alone and 28.7 % in association with infections). Other causes included nutritional dimorphic anemia and patients on treatment for megaloblastic anemia, acute lymphoblastic leukemia (during treatment) and lymphoma. Among various groups of RT, IL-6 and CRP levels were higher in patients with infection with or without IDA than IDA alone. One child with essential thrombocytosis and one child with RT had thrombotic complications. On follow up, platelet counts normalized in most of the patients with treatment of underlying conditions. Conclusions. Results of this study suggest that essential thrombocytosis is extremely rare in children. Infections and IDA (alone or in association with infections) are common causes of RT. IL-6 and CRP levels are increased in patients with RT, to a higher level in patients with infections than in patients with IDA. Most patients with RT have uneventful recovery of platelet counts to normal range with treatment for underlying condition.

Complicações tromboembólicas no paciente cirúrgico e sua profilaxia / Thromboembolic complications in surgical patients and its prophylaxis

INTRODUÇÃO: Complicações tromboembólicas tornam-se mais frequentes à medida que a população envelhece, pois o idoso apresenta com maior frequência fatores de risco como a imobilidade, procedimentos cirúrgicos, insuficiência venosa crônica, insuficiência cardíaca congestiva, neoplasias e outras doenças. O tromboembolismo venoso, causa de óbito hospitalar evitável mais comum no pós-operatório, engloba duas complicações principais: trombose venosa profunda e tromboembolismo pulmonar. Os fatores ligados à etiologia e patogenia do trombo compõem a Tríade de Rudolf Virchow que inclui lesão vascular endotelial, hipercoagulabilidade e estase venosa. Este artigo de revisão tem como objetivo evidenciar a importância de se conhecer as complicações tromboembólicas no paciente cirúrgico a fim de evitá-las.MÉTODOS: Foram selecionados os artigos com informações mais atualizadas sobre o assunto no Medline/PubMed, os quais mostraram que a tromboprofilaxia constitui a estratégia mais eficaz para reduzir morbidade e mortalidade por tromboembolismo venoso em pacientes cirúrgicos. A incidência de trombose venosa profunda proximal sem profilaxia encontra-se em torno de 25% a 32% e, com profilaxia, de 10% a 18%.CONCLUSÃO: Conhecer riscos de trombose venosa profunda pode aumentar a atenção em relação aos problemas de tromboembolismo pulmonar em pacientes hospitalizados e formar as bases de estratégias de profilaxia.

INTRODUCTION: Thromboembolic complications become more frequent in elderly, because they present risk factors more frequently, such as immobility, surgeries, chronic venous insufficiency, congestive heart failure, cancer and other diseases. The venous thromboembolism (VTE), the cause of preventable hospital death more common in post-operative, includes two main complications: deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE). The factors linked to the etiology and pathogenesis of thrombus up the Triad of Rudolf Virchow which includes vascular endothelial injury, hypercoagulability and venous stasis. This article aims to review, demonstrating the importance of understanding the thromboembolic complications in surgical patients in order to avoid them.METHODS: Information on the subject at Medline/PubMed, which showed that thromboprofylaxis is the most effective strategy to reduce morbidity and mortality in surgical patients by VTE. The incidence of proximal DVT without prophylaxis is around 25% to 32% and, with prophylaxis of 10% to 18%.CONCLUSION: Knowing risks of DVT may increase the focus on the problems of PTE in hospitalized patients and form the basis of strategies for prophylaxis.